Titan Pharmaceuticals
Pharmaceuticals, 400 Oyster Pt BLVD Ste 505, South San Francisco, California, 94080, United States, 11-50 Employees
Phone Number: 65********
Who is TITAN PHARMACEUTICALS
Titan Pharmaceuticals Inc. is developing proprietary therapeutics primarily for the treatment of serious medical disorders. The company's lead product is Probuphine, the first and only co...
Read More
-
Headquarters: 400 Oyster Pt BLVD Ste 505, South San Francisco, California, 94080, United States
-
Date Founded: 1992
-
Employees: 11-50
-
Revenue: $25 Million to $50 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 2834
|
NAICS Code: 551112 |
Show More
Does something look wrong? Fix it. | View contact records from TITAN PHARMACEUTICALS
Titan Pharmaceuticals Org Chart and Mapping
Email
Phone
Similar Companies to Titan Pharmaceuticals
Glenmark Pharmaceuticals
-
10001+
-
$ 500 Million to 1 Billion
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Titan Pharmaceuticals
Answer: Titan Pharmaceuticals's headquarters are located at 400 Oyster Pt BLVD Ste 505, South San Francisco, California, 94080, United States
Answer: Titan Pharmaceuticals's phone number is 65********
Answer: Titan Pharmaceuticals's official website is https://titanpharm.com
Answer: Titan Pharmaceuticals's revenue is $25 Million to $50 Million
Answer: Titan Pharmaceuticals's SIC: 2834
Answer: Titan Pharmaceuticals's NAICS: 551112
Answer: Titan Pharmaceuticals has 11-50 employees
Answer: Titan Pharmaceuticals is in Pharmaceuticals
Answer: Titan Pharmaceuticals top competitors include: Glenmark Pharmaceuticals
Answer: Titan Pharmaceuticals contact info: Phone number: 65******** Website: https://titanpharm.com
Answer: Titan Pharmaceuticals Inc. is developing proprietary therapeutics primarily for the treatment of serious medical disorders. The company's lead product is Probuphine, the first and only commercialized treatment of opioid dependence to provide continuous, around-the-clock blood levels of buprenorphine for six months following a single procedure. It was approved by the U.S. Food and Drug Administration in May 2016 and is being commercialized in the U.S. by partner Braeburn Pharmaceuticals. Probuphine employs Titan's proprietary drug delivery system ProNeuraTM, which is capable of delivering sustained, consistent levels of medication for up to 12 months. The ProNeura technology has the potential to be used in developing products for treating other chronic conditions such as Parkinson's disease and hypothyroidism, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month